Romo-González, M.; Moreno-Paz, S.; García-Hernández, V.; Sánchez-Guijo, F.; Hernández-Hernández, Á.
Inhibition of Xanthine Oxidoreductase Enhances the Potential of Tyrosine Kinase Inhibitors against Chronic Myeloid Leukemia. Antioxidants 2020, 9, 74.
https://doi.org/10.3390/antiox9010074
AMA Style
Romo-González M, Moreno-Paz S, García-Hernández V, Sánchez-Guijo F, Hernández-Hernández Á.
Inhibition of Xanthine Oxidoreductase Enhances the Potential of Tyrosine Kinase Inhibitors against Chronic Myeloid Leukemia. Antioxidants. 2020; 9(1):74.
https://doi.org/10.3390/antiox9010074
Chicago/Turabian Style
Romo-González, Marta, Sara Moreno-Paz, Violeta García-Hernández, Fermín Sánchez-Guijo, and Ángel Hernández-Hernández.
2020. "Inhibition of Xanthine Oxidoreductase Enhances the Potential of Tyrosine Kinase Inhibitors against Chronic Myeloid Leukemia" Antioxidants 9, no. 1: 74.
https://doi.org/10.3390/antiox9010074
APA Style
Romo-González, M., Moreno-Paz, S., García-Hernández, V., Sánchez-Guijo, F., & Hernández-Hernández, Á.
(2020). Inhibition of Xanthine Oxidoreductase Enhances the Potential of Tyrosine Kinase Inhibitors against Chronic Myeloid Leukemia. Antioxidants, 9(1), 74.
https://doi.org/10.3390/antiox9010074